Trial Profile
Comparative effect of daily teriparatide, weekly teriparatide, or bisphosphonate on bone microarchitecture in patients with primary osteoporosis: A HR-pQCT study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2020
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Bisphosphonates
- Indications Osteoporosis
- Focus Therapeutic Use
- 31 Jul 2020 Status changed from recruiting to completed.
- 27 May 2016 New trial record